Where does Hugo Fry work?

Hugo Fry is Chief Executive Officer at Topas Therapeutics.

Where did Hugo Fry go to school?

Hugo Fry studied at London Business School (Finance); Duke University (Leadership); The University of Salford (BSc, Chemistry).

Hugo Fry

Chief Executive Officer at Topas Therapeutics

London, England, United Kingdom

Find your path to Hugo

211 people in our graph share verified history with Hugo — schools, employers, funds. One of them is your warm intro.

Jack Bixby LucasunlockedHugo: together at Duke University (2014)

×5Hugo: together at London Business School

×4Hugo: together at Duke University

Hugo: together at Servier

Chief Executive Officer at Topas Therapeutics

Intro paths

→

In turn, Hugo can intro founders to Topas Therapeutics's investors below.

Topas Therapeutics's investors · 5

BioMedPartnersBasel · $648K – $6.5M checks Boehringer Ingelheim Venture FundIngelheim am Rhein · $16.2M checks EMBL VenturesHeidelberg · $108K – $5.4M checks Epidarex CapitalBethesda · $2.5M – $6.3M checks GimvAntwerp · $21M – $430M checks

Experience

Topas Therapeutics GmbHChief Executive Officercurrent2024 — presentHamburg, Germany
20Med TherapeuticsChief Business Officer and Managing Director2023 — 2025Leiden, South Holland, Netherlands
Zen IntelligenceChair of The Board2021 — 2024Greater London, England, United Kingdom
Imbria PharmaceuticalsChief Commercial Officer2021 — 2024Boston, Massachusetts, United States
RQ Biotechnology Ltd.Chief Executive Officer2022 — 2023Greater London, England, United Kingdom
Advisor | Board MemberLife Science Leader | Pharmaceuticals and Biotech | Commercial, R&D, Industrial Affairs2021 — 2022
SanofiManaging Director – UK ► Commercial, Industrial, R&D | Innovative Healthcare Solutions2017 — 2021United Kingdom
The Association of the British Pharmaceutical Industry (ABPI)Vice President ► Executive Leadership in Biosciences2019 — 2021United Kingdom
The Association of the British Pharmaceutical Industry (ABPI)Board Member ► Executive Leadership in Biosciences2016 — 2021United Kingdom
Sanofi Pasteur MSDVice President, Chief Marketing Officer ► Commercial Strategy | Business Development2015 — 2016Lyon; Paris
sanofiGlobal Project Leader, Lixisenatide Family ► Cross-Functional Team Leadership | Pharmaceuticals2011 — 2014Frankfurt; New Jersey; Paris
ZentivaGeneral Manager ► International Business | Revenue Growth | Integration Management2010 — 2011Moscow, Russia
sanofi-aventisBusiness Unit Director - Russia ► Commercial Operations | Oncology | Diabetes | Cardio-Hospital2008 — 2010
sanofi-aventisMarketing Director - Russia ► Marketing Strategy | Portfolio Management2007 — 2008
sanofi-aventisMarketing Support Director - Global Marketing ► Franchise Management2005 — 2006
AVENTIS PHARMA LIMITEDHead of Commercial Excellence ► Sales & Marketing Management2003 — 2004
ServierBrand Director | GM | Product, Sales & Training Manager ► Regional & Global Roles1994 — 2003

Skills & more

Pharmaceutical Sales58Pharmaceutical Industry61Strategy38Market Access57Hospital Sales5Diabetes25Oncology14Product Launch12Cardiology2Cross-functional Team Leadership4Endocrinology2Marketing3

+8 more

Drug DevelopmentMarket AnalysisSales EffectivenessGlobal MarketingClinical DevelopmentRegulatory AffairsMedical AffairsMedical Devices

Languages English · French

From Hugo's professional profile.

Frequently asked questions

Who is Hugo Fry?: Chief Executive Officer at Topas Therapeutics
Where does Hugo Fry work?: Hugo Fry is Chief Executive Officer at Topas Therapeutics.
Where did Hugo Fry go to school?: Hugo Fry studied at London Business School (Finance); Duke University (Leadership); The University of Salford (BSc, Chemistry).

Same school

Also attended London Business School906

Patrick ClaessenPartner at Cottonwood Technology Fund Dominic JacquessonInvestor at Index Ventures Sandra SchwarzerInvestor at Index Ventures Matt CherianVenture Partner at Monta Vista Capital Akshat GoenkaInvestor at Moonfire Ventures Giuseppe IademarcoHead of Global Partnership at P101 Ventures

+ 900 more

Also attended Duke University948

Marc AndreessenCo-founder & General Partner at Andreessen Horowitz Fred EhrsamCo-founder and Senior Advisor at Paradigm; founder of Nudge Jeremy LevinePartner at Bessemer Venture Partners Zach PerretCo-founder & CEO of Plaid; co-founder of Mischief Julie YangVice President at Investcorp Ayaan PatelInvestor at Lightbank

+ 942 more

Also attended The University of Salford35

Edward LamDirector of Finance at The Spartan Group Essi HänninenOffice Manager at Innovestor Ventures Jim WilkinsonCFO at Oxford Science Enterprises Joe KellettInvestor at M33 Growth Edward Vaughan LuiPartner, Head of Impact at Bridges Fund Management Ltd.Ben HarrisonSenior Consultant at Resonance

+ 29 more

Shared employers

Also worked at 20Med Therapeutics2

Michel BaijotChairman at White Fund Suvi HaimiFounder at Sulapac

Also worked at Sanofi248

Steve LiapisManaging Director at Northpond Ventures Walter OlesiakOperating Partner at Remiges Ventures, Inc.Christine AylwardFounder & Managing Partner at Magnetic Ventures Alan WaltsVenture Partner at Advent Life Sciences Sun AltbachSenior Scientific Advisor at BOLD Longevity Matt VineSenior Associate at RRE Ventures

+ 242 more

Also worked at Sanofi Pasteur MSD2

Laetitia SchwabPrincipal at SR One Capital Management Celeste FernandezInvestor at Proeza Ventures

Also worked at Zentiva2

Andreas HalnerFounder and Head of Healthcare AI at OxCan (Oxford Cancer Analytics)Xavier LasserreChief Commercial Operations Officer at Ethypharm